Beacon Biosignals

Beacon Biosignals

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.beacon.bio

Last Round

Series B

Extension

Apr 6, 2026

Est. Valuation

$286.85M

Total Funding Raised

$138M

Momentum Score

75 /100

Company Overview

Beacon Biosignals is a healthcare technology company that offers an artificial intelligence-driven EEG analysis and diagnosis platform aimed at enhancing human health through rapid, targeted interventions and advanced brain analytics.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical AI, ML Platforms, Healthcare Analytics, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

EEG data analysisneurobiomarkersAI for clinical trialsclinical trial supportbiomarker discoveryneuroanalytics platformwearable EEGdigital biomarkerssleep studiesCNS drug developmentsleep stagingbrain biomarkersFDA-cleared medical deviceat-home monitoringneurotechdecentralized clinical trialsneurological disorderssleep disorders

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beacon Biosignals Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Beacon Biosignals Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionApr 6, 2026
Series BNov 13, 2025
Series ANov 8, 2021
SeedMay 30, 2019

Key People

Founding team and executive leadership

Jacob Donoghue

Co-Founder And CEO

Founding Team

Jarrett Revels

Chief Technology Officer

Executive Team

Beacon Biosignals Investors

Notable investors and investment history

InvestorRounds
S32Series B
Kicker VenturesSeries B, Series B Extension
GVSeries B Extension, Series B
JSL Health CapitalSeries B, Series B Extension
Nexus NeuroTech VenturesSeries B, Series B Extension
InnovivaSeries B Extension, Series B
Catalio Capital ManagementSeries B, Series B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Attending the 2026 American Academy of Neurology Annual Meeting.

  • Apr 6, 2026

    $11M raised in Series B Extension round.

Beacon Biosignals Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Beacon Biosignals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beacon Biosignals's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range115
Year Founded2019
Last FundingApr 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.